| Popis: |
Md Anwarul Azim Majumder,1,2 Keerti Singh,2 WMS Johnson,3 Archana Rajasundaram,3 Subir Gupta,2 Uma Gaur,2 Santosh Kumar,4 Madhuri Chatterjee,5 Ahbab Mohammad Fazle Rabbi,6 Vijay Prasad Sangishetti,7 Sayeeda Rahman,8 Michael H Campbell,2 Heather Harewood,2 Ambadasu Bharatha,2 Kandamaran Krishnamurthy,2 Russell Kabir,9 Ali Davod Parsa,9 Shegufta Mohammmad,10 Mainul Haque,11 Mohammed S Razzaque12 1Public Health Foundation of Bangladesh, Dhaka, Bangladesh; 2Faculty of Medical Sciences, The University of the West Indies, Bridgetown, Barbados; 3Department of Anatomy, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India; 4Karnavati School of Dentistry, Karnavati University, Ahmedabad, Gujarat, India; 5Department of Pharmacology, Shri Ramkrishna Institute of Medical Science, Durgapur, West Bengal, India; 6Department of Population Sciences, University of Dhaka, Dhaka, Bangladesh; 7Department of Pharmacology, Govt. Medical College, Shivpuri, Madhya Pradesh, India; 8School of Medicine, American University of Integrative Sciences (AUIS), Bridgetown, Barbados; 9Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Chelmsford, Essex, UK; 10BRAC Learning Division, BRAC University, Dhaka, Bangladesh; 11Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, 57000, Malaysia; 12Lake Erie College of Osteopathic Medicine, Erie, PA, USACorrespondence: WMS Johnson, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India, Email johnsonmoses@gmail.com; johnsonmoses@yahoo.com Mainul Haque, Faculty of Medicine and Defence Health, National Defence University of Malaysia, Kuala Lumpur, Malaysia, Email runurono@gmail.com; mainul@upnm.edu.myBackground: Efficacy and safety are fundamental for the development of successful COVID-19 vaccines. Vaccine-associated side effects influence vaccine hesitancy. This study investigated the prevalence, severity, and onset of side effects following the first dose of COVID-19 vaccines among physicians and dentists working in various healthcare settings across India.Methods: A cross-sectional survey collected self-report data from April to June 2021 on side effects following the first dose of the vaccine. An online validated questionnaire using the Google Docs® platform was circulated via email and social media platforms.Results: More than 40% of participants experienced at least one side effect after the first dose of vaccination; the most common were mild and resolved within three days after vaccination. More than 91% of respondents received the Covishield (AstraZeneca) vaccine; the most prevalent adverse effects were soreness of the injected arm (78.9%), tiredness (71.1%), and fever (54.9%). Logistic regression showed that women were almost 60% less likely to report side effects.Conclusion: Findings supported the safety of the first dose of the COVID-19 vaccine based on relatively few self-limiting side effects, mainly soreness of the injected arm and tiredness. Further research is needed to determine the long-term safety of COVID-19 vaccines, especially after booster doses.Keywords: prevalence, adverse effects, COVID-19 vaccine, physicians, dentists, India |
